Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Ajinomoto

  • GEN | Biolinks
    AgroBIO Mexico Ajinomoto Akebia Therapeutics Alabama Development Office Alaska Division of Economic Development Aldagen Alder Biopharmaceuticals Aldevron Alethia Biotherapeutics ...
  • Ajinomoto Moves into CDMO Market
    Ajinomoto agreed to take over Althea Technologies, a contract development and ... stock for $175 million. According to an Ajinomoto official, the CMDO market is estimated ...
    3-6-2013
  • 25 Diabetes Drugs in the Pipeline Right Now
    ... study, set to start first half of 2013) Starsis (nateglinide) Sponsor/Developer: Ajinomoto and Astellas Mechanism of action: Insulin secretion enhancer Indication (Phase): ...
    11-30-2012
  • Options for Producing Antibody Fragments
    Here's advice on how to produce the fragments themselves. Secretion of accurately folded protein via Corynebacterium glutamicum . [Ajinomoto] Antibody-drug conjugates (ADCs) have ...
    10-4-2012
  • Reducing Peptide Synthesis Costs
    ... SPPS and LPPS concepts is Ajinomoto. Daisuke Takahashi, chief, Research Institute for Bioscience Products and Fine Chemicals at Ajinomoto, described the company's new approach. ...
    7-1-2012
  • Scale-Up Woes Hinder Protein Purification
    ... Competition Secretion of accurately folded protein via Corynebacterium glutamicum . [Ajinomoto] Since designing ease of purification into molecules is difficult, bioprocessors will ...
    5-1-2011
  • Expression Systems Break with Tradition
    Streamlined Methods Stray from Classic Hosts to Produce Higher Yields in Fewer Steps The challenge to produce more protein faster is leading to the development of new, engineered ...
    3-15-2011
  • Boehringer Ingelheim Enters Deal with DeveloGen with an Initial...
    co-transporter 2) inhibitors in Phase II development: BI 44847 was in-licensed from Ajinomoto, and BI 10773 has been developed through in-house research. ♦♦♦ Past News from ...
    5-13-2009

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll